Allphase Clinical Research Revenue and Competitors

Ottawa, ON CAN

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Allphase Clinical Research's estimated annual revenue is currently $6.8M per year.(i)
  • Allphase Clinical Research's estimated revenue per employee is $201,000

Employee Data

  • Allphase Clinical Research has 34 Employees.(i)
  • Allphase Clinical Research grew their employee count by -41% last year.

Allphase Clinical Research's People

NameTitleEmail/Phone
1
Project ManagerReveal Email/Phone
2
Manager Clinical OperationsReveal Email/Phone
3
Finance ManagerReveal Email/Phone
4
Senior Manager, Data ManagementReveal Email/Phone
5
PresidentReveal Email/Phone
6
Clinical Study AssociateReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$18.5M92-1%N/AN/A
#2
$14.3M716%N/AN/A
#3
$36M1798%N/AN/A
#4
$7.8M398%N/AN/A
#5
$17.9M933%$192.2MN/A
#6
$64.9M3234%N/AN/A
#7
$0.5M5-55%N/AN/A
#8
$6.8M34-41%N/AN/A
#9
$19.5M9723%N/AN/A
#10
$2.5M2519%N/AN/A
Add Company

What Is Allphase Clinical Research?

Allphase Clinical Research is a full-service clinical development company providing clinical trial management services, including regulatory affairs, project management, clinical monitoring, data management, quality assurance auditing, drug safety, and medical writing. Allphase provides Phase I to IV support throughout a wide range of therapeutic areas, with a predominant focus in oncology, CNS, and critical care diseases. Allphase provides integrative and strategic clinical trial services that allow our international partners to realize the advantages of conducting clinical trails in North America, while reinforcing therir global development cpabilities.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$6.8M

Revenue (est)

-41%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Allphase Clinical Research News

2022-04-20 - Regeneron to Acquire Checkmate for $250M, Expanding ...

Vidutolimod is also under study in three other clinical trials, including: CMP-001-011, a randomized Phase II/III trial (NCT04695977) comparing...

2022-04-19 - Alston & Bird Health Care Week In Review, April 15, 2022 ...

This draft guidance addresses FDA's recommendations regarding clinical trials for drugs being developed for the treatment of celiac disease...

2022-04-13 - Recce Pharmaceuticals Announces Phase I Clinical Trial of ...

The study is on track to complete all Phase I dosing by Q2 2022. According to PEW Charitable Trusts Global Antibiotic pipeline review, R327 is...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A34N/AN/A
#2
$4.4M3470%N/A
#3
$6.8M35-3%N/A
#4
$3.9M3530%$7M
#5
$75M353%N/A